Granzyme B in aging and age-related pathologies.
Abstract
Aging is a major risk factor for pathologies that manifest later in life. Much attention is devoted towards elucidating how prolonged environmental exposures and inflammation promote biological (accelerated) tissue aging. Granzymes, a family of serine proteases, are increasingly recognized for their emerging roles in biological aging and disease. Widely recognized as intracellular mediators of cell death, granzymes, particularly granzyme B (GzmB), also accumulate in the extracellular milieu of tissues with age, contributing to chronic tissue injury, inflammation, and impaired healing. Consequently, this has prompted the field to reconsider how GzmB regulation, accumulation, and proteolysis impact health and disease with age. While GzmB is observed in numerous age-related conditions, the current review focuses on mechanistic studies where proof-of-concept has been forwarded.
The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.
Research summary
The paper discusses granzyme B's role in aging and age-related pathologies, focusing on its accumulation and effects on chronic tissue injury and inflammation. While it addresses mechanisms related to aging, it does not propose solutions to the root causes of aging or lifespan extension. The findings contribute to understanding the role of granzymes in aging but represent a solid yet limited impact in the broader context of longevity research.
Author of this paper? Send a correction.